Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9102203 | Endocrinología y Nutrición | 2005 | 9 Pages |
Abstract
Secondary osteoporosis is caused by another medical condition or by drugs. Glucocorticoid-induced osteoporosis (GIOP) is the second in frequency only after the osteoporosis that occurs after menopause and is the most common form of drug-induced osteoporosis. It is estimated that over 50% of chronic glucocorticoid users will develop bone loss leading to fracture. We use a case of GIOP to review areas of continued controversy, including the pathogenesis of GIOP, methods for diagnosis of GIOP, and an evidence-based approach for both GIOP prevention and treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
J. Escalada,